vs
Side-by-side financial comparison of Installed Building Products, Inc. (IBP) and Revvity (RVTY). Click either name above to swap in a different company.
Revvity is the larger business by last-quarter revenue ($772.1M vs $747.5M, roughly 1.0× Installed Building Products, Inc.). Revvity runs the higher net margin — 12.7% vs 10.2%, a 2.5% gap on every dollar of revenue. On growth, Revvity posted the faster year-over-year revenue change (5.9% vs -0.4%). Revvity produced more free cash flow last quarter ($161.8M vs $49.3M). Over the past eight quarters, Revvity's revenue compounded faster (9.0% CAGR vs 3.9%).
Installed Building Products, Inc. is a leading US-based provider of professional installation services for building products. Core offerings include insulation, gutters, garage doors, fire protection systems and window treatments, serving residential new construction, repair & remodel, and commercial construction segments across most US regions.
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
IBP vs RVTY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $747.5M | $772.1M |
| Net Profit | $76.6M | $98.4M |
| Gross Margin | 35.0% | — |
| Operating Margin | 14.6% | 14.5% |
| Net Margin | 10.2% | 12.7% |
| Revenue YoY | -0.4% | 5.9% |
| Net Profit YoY | 14.5% | 3.9% |
| EPS (diluted) | $2.81 | $0.86 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $747.5M | $772.1M | ||
| Q3 25 | $778.2M | $698.9M | ||
| Q2 25 | $760.3M | $720.3M | ||
| Q1 25 | $684.8M | $664.8M | ||
| Q4 24 | $750.2M | $729.4M | ||
| Q3 24 | $760.6M | $684.0M | ||
| Q2 24 | $737.6M | $691.7M | ||
| Q1 24 | $692.9M | $649.9M |
| Q4 25 | $76.6M | $98.4M | ||
| Q3 25 | $74.4M | $46.7M | ||
| Q2 25 | $69.0M | $53.9M | ||
| Q1 25 | $45.4M | $42.2M | ||
| Q4 24 | $66.9M | $94.6M | ||
| Q3 24 | $68.6M | $94.4M | ||
| Q2 24 | $65.2M | $55.4M | ||
| Q1 24 | $55.9M | $26.0M |
| Q4 25 | 35.0% | — | ||
| Q3 25 | 34.0% | 53.6% | ||
| Q2 25 | 34.2% | 54.5% | ||
| Q1 25 | 32.7% | 56.5% | ||
| Q4 24 | 33.6% | — | ||
| Q3 24 | 33.8% | 56.3% | ||
| Q2 24 | 34.1% | 55.7% | ||
| Q1 24 | 33.8% | 54.6% |
| Q4 25 | 14.6% | 14.5% | ||
| Q3 25 | 13.7% | 11.7% | ||
| Q2 25 | 13.3% | 12.6% | ||
| Q1 25 | 10.2% | 10.9% | ||
| Q4 24 | 13.1% | 16.3% | ||
| Q3 24 | 13.3% | 14.3% | ||
| Q2 24 | 12.9% | 12.4% | ||
| Q1 24 | 12.7% | 6.8% |
| Q4 25 | 10.2% | 12.7% | ||
| Q3 25 | 9.6% | 6.7% | ||
| Q2 25 | 9.1% | 7.5% | ||
| Q1 25 | 6.6% | 6.4% | ||
| Q4 24 | 8.9% | 13.0% | ||
| Q3 24 | 9.0% | 13.8% | ||
| Q2 24 | 8.8% | 8.0% | ||
| Q1 24 | 8.1% | 4.0% |
| Q4 25 | $2.81 | $0.86 | ||
| Q3 25 | $2.74 | $0.40 | ||
| Q2 25 | $2.52 | $0.46 | ||
| Q1 25 | $1.64 | $0.35 | ||
| Q4 24 | $2.39 | $0.77 | ||
| Q3 24 | $2.44 | $0.77 | ||
| Q2 24 | $2.30 | $0.45 | ||
| Q1 24 | $1.97 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $321.9M | $919.9M |
| Total DebtLower is stronger | $886.6M | — |
| Stockholders' EquityBook value | $709.9M | $7.3B |
| Total Assets | $2.1B | $12.2B |
| Debt / EquityLower = less leverage | 1.25× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $321.9M | $919.9M | ||
| Q3 25 | $333.3M | $931.4M | ||
| Q2 25 | $305.2M | $991.8M | ||
| Q1 25 | $298.7M | $1.1B | ||
| Q4 24 | $327.6M | $1.2B | ||
| Q3 24 | $406.2M | $1.2B | ||
| Q2 24 | $380.3M | $2.0B | ||
| Q1 24 | $399.9M | $1.7B |
| Q4 25 | $886.6M | — | ||
| Q3 25 | $880.8M | — | ||
| Q2 25 | $876.1M | — | ||
| Q1 25 | $872.4M | — | ||
| Q4 24 | $874.8M | — | ||
| Q3 24 | $872.3M | — | ||
| Q2 24 | $875.8M | — | ||
| Q1 24 | $875.0M | — |
| Q4 25 | $709.9M | $7.3B | ||
| Q3 25 | $678.6M | $7.4B | ||
| Q2 25 | $664.5M | $7.6B | ||
| Q1 25 | $660.9M | $7.6B | ||
| Q4 24 | $705.3M | $7.7B | ||
| Q3 24 | $716.4M | $7.9B | ||
| Q2 24 | $685.3M | $7.9B | ||
| Q1 24 | $679.2M | $7.8B |
| Q4 25 | $2.1B | $12.2B | ||
| Q3 25 | $2.1B | $12.1B | ||
| Q2 25 | $2.0B | $12.4B | ||
| Q1 25 | $2.0B | $12.4B | ||
| Q4 24 | $2.1B | $12.4B | ||
| Q3 24 | $2.1B | $12.8B | ||
| Q2 24 | $2.0B | $13.4B | ||
| Q1 24 | $2.0B | $13.4B |
| Q4 25 | 1.25× | — | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 1.32× | — | ||
| Q1 25 | 1.32× | — | ||
| Q4 24 | 1.24× | — | ||
| Q3 24 | 1.22× | — | ||
| Q2 24 | 1.28× | — | ||
| Q1 24 | 1.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.9M | $182.0M |
| Free Cash FlowOCF − Capex | $49.3M | $161.8M |
| FCF MarginFCF / Revenue | 6.6% | 21.0% |
| Capex IntensityCapex / Revenue | 2.1% | 2.6% |
| Cash ConversionOCF / Net Profit | 0.85× | 1.85× |
| TTM Free Cash FlowTrailing 4 quarters | $300.8M | $509.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.9M | $182.0M | ||
| Q3 25 | $124.0M | $138.5M | ||
| Q2 25 | $90.4M | $134.3M | ||
| Q1 25 | $92.1M | $128.2M | ||
| Q4 24 | $74.8M | $174.2M | ||
| Q3 24 | $101.4M | $147.9M | ||
| Q2 24 | $79.0M | $158.6M | ||
| Q1 24 | $84.8M | $147.6M |
| Q4 25 | $49.3M | $161.8M | ||
| Q3 25 | $104.8M | $120.0M | ||
| Q2 25 | $74.8M | $115.5M | ||
| Q1 25 | $71.9M | $112.2M | ||
| Q4 24 | $52.9M | $149.8M | ||
| Q3 24 | $77.3M | $125.6M | ||
| Q2 24 | $58.2M | $136.6M | ||
| Q1 24 | $63.0M | $129.7M |
| Q4 25 | 6.6% | 21.0% | ||
| Q3 25 | 13.5% | 17.2% | ||
| Q2 25 | 9.8% | 16.0% | ||
| Q1 25 | 10.5% | 16.9% | ||
| Q4 24 | 7.1% | 20.5% | ||
| Q3 24 | 10.2% | 18.4% | ||
| Q2 24 | 7.9% | 19.7% | ||
| Q1 24 | 9.1% | 20.0% |
| Q4 25 | 2.1% | 2.6% | ||
| Q3 25 | 2.5% | 2.6% | ||
| Q2 25 | 2.1% | 2.6% | ||
| Q1 25 | 2.9% | 2.4% | ||
| Q4 24 | 2.9% | 3.4% | ||
| Q3 24 | 3.2% | 3.3% | ||
| Q2 24 | 2.8% | 3.2% | ||
| Q1 24 | 3.1% | 2.7% |
| Q4 25 | 0.85× | 1.85× | ||
| Q3 25 | 1.67× | 2.97× | ||
| Q2 25 | 1.31× | 2.49× | ||
| Q1 25 | 2.03× | 3.03× | ||
| Q4 24 | 1.12× | 1.84× | ||
| Q3 24 | 1.48× | 1.57× | ||
| Q2 24 | 1.21× | 2.87× | ||
| Q1 24 | 1.52× | 5.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IBP
| Residential New Construction | $488.6M | 65% |
| Other Customer Installation | $67.8M | 9% |
| Shower Doors Shelving And Mirrors | $53.5M | 7% |
| Other Building Products | $47.7M | 6% |
| Fireproofing And Firestopping | $37.6M | 5% |
| Rain Gutters | $31.3M | 4% |
| Window Blinds | $18.0M | 2% |
| Related Party | $6.7M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
